Forecast: Measles-Containing-Vaccine Second-Dose (MCV2) Immunization Coverage in Singapore

The Measles-Containing-Vaccine Second-Dose (MCV2) immunization coverage in Singapore has shown a stable trend over the past decade, with values predominantly in the range of 88-94%. In 2023, the coverage stood at 92%. A slight dip occurred in 2016 and 2021, but the overall trajectory displayed a consistent improvement.

Key Insights:

• From 2013 to 2023, the year-on-year variations generally remained low, indicating stability in the immunization program.
• The highest coverage was observed in 2020 at 94%.
• The Compound Annual Growth Rate (CAGR) between 2019 and 2023 averaged at 0.22%.

Projected Future Trends:

• Coverage is expected to stabilize at 92% from 2024 to 2028.
• No significant year-on-year variations or growth in the forecast period, suggesting a plateau in immunization rates.
• Trends to watch for include potential impacts of healthcare policies, public health initiatives, and emerging health threats on future immunization rates.